Skip to main content

LYVE-1 Products

Lymphatic Vessel Endothelial Hyaluronan (HA) Receptor-1 (LYVE-1) is a 60-kDa type I transmembrane glycoprotein that is a member of the Link Protein superfamily. HA is found in the extracellular matrix of most animal tissues and in body fluids. It modulates cell behavior and functions during tissue remodeling, development, homeostasis, and disease. It is often used as a marker of lymphatic endothelia.

LYVE-1 is expressed on both the lumenal and ablumenal surfaces of lymphatic endothelium, and also on hepatic blood sinusoidal endothelia. This expression pattern, combined with studies showing that LYVE-1 can support cellular HA internalization in vitro, may suggest LYVE-1 participation in HA internalization for degradation, or transport of HA from tissues into the lumen of lymphatic vessels. LYVE-1-directed HA localization to lymphatic surfaces might also affect aspects of the immune response or tumor metastases. HA binding to CD44 can still occur in the presence of LYVE-1 in vitro. Therefore, LYVE-1-directed HA localization to lymphatics could provide a substrate for transmigrating CD44+ leukocytes or tumor cells. In addition to hepatic and lymphatic endothelia, some expression of LYVE-1 has been reported on Kupffer cells, the islets of Langerhans, cortical neurons, and renal epithelium. Roles for LYVE-1 on these cell and tissue types remain to be determined.

Show More

204 results for "LYVE-1" in Products

Back to Search Results
Apply

204 results for "LYVE-1" in Products

LYVE-1 Products

Lymphatic Vessel Endothelial Hyaluronan (HA) Receptor-1 (LYVE-1) is a 60-kDa type I transmembrane glycoprotein that is a member of the Link Protein superfamily. HA is found in the extracellular matrix of most animal tissues and in body fluids. It modulates cell behavior and functions during tissue remodeling, development, homeostasis, and disease. It is often used as a marker of lymphatic endothelia.

LYVE-1 is expressed on both the lumenal and ablumenal surfaces of lymphatic endothelium, and also on hepatic blood sinusoidal endothelia. This expression pattern, combined with studies showing that LYVE-1 can support cellular HA internalization in vitro, may suggest LYVE-1 participation in HA internalization for degradation, or transport of HA from tissues into the lumen of lymphatic vessels. LYVE-1-directed HA localization to lymphatic surfaces might also affect aspects of the immune response or tumor metastases. HA binding to CD44 can still occur in the presence of LYVE-1 in vitro. Therefore, LYVE-1-directed HA localization to lymphatics could provide a substrate for transmigrating CD44+ leukocytes or tumor cells. In addition to hepatic and lymphatic endothelia, some expression of LYVE-1 has been reported on Kupffer cells, the islets of Langerhans, cortical neurons, and renal epithelium. Roles for LYVE-1 on these cell and tissue types remain to be determined.

Show More
Applications: WB, IHC, Dual ISH-IHC
Reactivity: Mouse
Applications: WB, IHC, Block
Reactivity: Human
Applications: WB, Flow, IHC, Block, CyTOF-ready, ICC
Reactivity: Mouse
Applications: WB, IHC
Reactivity: Mouse
Applications: IHC, WB, Flow, CyTOF-ready
Reactivity: Human, Mouse, Rat
Applications: IHC, WB
Reactivity: Human, Mouse
Applications: IHC, WB, ICC/IF, Flow
Reactivity: Human, Mouse, Rat
Applications: Flow
Reactivity: Mouse
Applications: Flow
Reactivity: Mouse
Applications: Flow
Reactivity: Mouse
Applications: WB
Reactivity: Human
Applications: IHC, WB, ICC/IF, Flow
Reactivity: Human, Mouse, Rat
Applications: Flow
Reactivity: Human
Applications: WB, IHC
Reactivity: Human
Applications: IHC, WB, Flow, CyTOF-ready
Reactivity: Human
Applications: Block
Reactivity: Human
Applications: WB, IHC
Reactivity: Rat
Applications: Flow
Reactivity: Human
Applications: Flow
Reactivity: Human
Applications: Flow
Reactivity: Human
Applications: WB
Reactivity: Human, Mouse
Applications: Flow
Reactivity: Mouse
Applications: Flow
Reactivity: Human
Results Per Page
5 10 25 50
/ 9